Glutamine supplementation in a child with inherited GS deficiency improves the clinical status and partially corrects the peripheral and central amino acid imbalance

Abstract

Glutamine synthetase (GS) is ubiquitously expressed in mammalian organisms and is a key enzyme in nitrogen metabolism. It is the only known enzyme capable of synthesising glutamine, an amino acid with many critical roles in the human organism. A defect in GLUL, encoding for GS, leads to congenital systemic glutamine deficiency and has been described in three patients with epileptic encephalopathy. There is no established treatment for this condition.Here, we describe a therapeutic trial consisting of enteral and parenteral glutamine supplementation in a four year old patient with GS deficiency. The patient received increasing doses of glutamine up to 1020 mg/kg/day. The effect of this glutamine supplementation was monitored clinically, biochemically, and by studies of the electroencephalogram (EEG) as well as by brain magnetic resonance imaging and spectroscopy.Treatment was well tolerated and clinical monitoring showed improved alertness. Concentrations of plasma glutamine normalized while levels in cerebrospinal fluid increased but remained below the lower reference range. The EEG showed clear improvement and spectroscopy revealed increasing concentrations of glutamine and glutamate in brain tissue. Concomitantly, there was no worsening of pre-existing chronic hyperammonemia.In conclusion, supplementation of glutamine is a safe therapeutic option for inherited GS deficiency since it corrects the peripheral biochemical phenotype and partially also improves the central biochemical phenotype. There was some clinical improvement but the patient had a long standing severe encephalopathy. Earlier supplementation with glutamine might have prevented some of the neuronal damage.

Worsening of Seizures After Asparagine Supplementation in a Child with Asparagine Synthetase Deficiency

“…2 Later, we reported two more cases from the same family with similar clinical features and, for the first time, cerebrospinal fluid findings were reported on the two siblings with low asparagine levels. 3 The pathophysiology of the disease was suggested as being due to asparagine deficiency similar to glutamine 4 and serine synthesis defects. 5 The possibility of neurotoxicity from excessive excitatory neurotransmitters was entertained as well.…”

Effect of glutamine ingestion on the progression of induced periodontitis: experimental study in rats

“…Glutamine use was evaluated in a clinical trial with children in severe disease states. The results demonstrated that it has a beneficial effect on brain activity and the decrease of ammonia in the body 4 . Furthermore, the findings indicated that glutamine is systemically safe and could be administered in different ways 4,5 .…”

N-of-1 genomic medicine for the rare pediatric genetic diseases

“…In contrast, N-of-1 studies involve trial, assessment, and modification of care in an individual patient. In the context of research, N-of-1 trials are generally published as case reports [15][16][17][18][19]. Gabler et al [20] and Duan et al [21] recently published a comprehensive review of single patient trials.…”